Risk of urinary adverse effects of bevacizumab therapy in patients with ovarian cancer: a systematic review and meta-analysis. Arch Ital Urol Androl [Internet]. 2025 Dec. 24 [cited 2026 Apr. 29];97(4). Available from: https://www.pagepressjournals.org/aiua/article/view/14659